SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 21, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 4/10
Horizondays Processed2mo ago
Insider cluster: 4 insiders, $8.5M total
Actionable Insight • Neutral

The cluster is small relative to market cap and dominated by a single insider's cashless option exercise/sale pattern, which is typical for tax planning. Monitor for any 8-K or press release that could explain the timing, the stock's recent +23% run may simply be providing a favorable exit window. No immediate bearish read-through given the proportionality and academic evidence that cluster sales are not predictive.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$140.80
T+0 close · Aug 21, 2026 · via day close
Latest settled
+16.90%
T+20 · $164.60 · next T+60 in 12h
Vs SPY
+15.61%
α at T+20
Latest observation
−0.48%
T+57 · FF3 residual α
  1. T+0 · Aug 24 $140.80entry
  2. T+1 · 3mo ago +7.54%α +7.22% · $151.42
  3. T+5 · 3mo ago −1.28%α −1.75% · $139.00
  4. T+20 · 8w ago +16.90%α +15.61% · $164.60
  5. T+59 · todayOpen
  6. T+60 · in 12h Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four Twist Bioscience insiders, including CEO Emily Leproust and President/COO Patrick Finn, sold a total of $8.48M in stock over a 7-day window. The cluster is dominated by the President/COO's $11.0M in sales (including cashless exercise of options) and the CEO's $2.5M sale. While the dollar amount is modest relative to the $9.0B market cap (~0.09%), the concentration of C-suite selling at elevated prices near all-time highs warrants attention, though the academic literature finds cluster sales are not reliably informative.

Key Financial Metrics

Direction
selling
Total Value
$8.5M
Insiders
4

Key Facts

  • 4 insiders sold a total of $8.48M in TWST stock over 7 days
  • CEO Emily Leproust sold 20,000 shares for $2.50M on 2026-08-12
  • President/COO Patrick Finn sold ~78,355 shares for $11.0M (including cashless option exercises) on 2026-08-18
  • Director Katryn Blake sold 2,200 shares for $275K on 2026-08-12
  • VP Dennis Cho sold 14,205 shares for $1.84M on 2026-08-19
  • Total sales represent ~0.09% of TWST's $9.0B market cap
  • Stock is up ~23% in the past 2 weeks and trading near all-time highs

Financial Impact

Total insider sales of $8.48M represent ~0.09% of market cap, below the 0.1% materiality threshold

insider ownershipdilution

Risk Factors

  • C-suite selling at elevated prices could signal peak sentiment or insider caution
  • CEO and President/COO selling simultaneously may raise governance questions
  • Stock's recent parabolic move (+23% in 2 weeks) increases mean-reversion risk

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TWST-1787379007205

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 22, 2026